Ironwood Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Ironwood Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ironwood Pharmaceuticals Inc Strategy Report
- Understand Ironwood Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Ironwood Pharmaceuticals Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Ironwood Pharmaceuticals Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 28 Jan 2020 | Lorem |
| Ardelyx’s tenapanor has passable risk/benefit profile for positive Phase III T3MPO-2 results, but diarrhoea a sticking point for future in IBS-C – experts | 14 Aug 2017 | Jennifer C. Smith-Parker, Surani Fernando |
| Ironwood’s Phase IIb IW-3718 trial in GERD has unclear outcomes with statistical absences despite previous positive efficacy signal – experts | 28 Feb 2017 | Alexandra Thompson |
| Synergy’s Trulance’s reimbursement prospects weak vs Ironwood’s Linzess, uptake in CIC debatable considering lack of comparison trial – experts | 26 Jan 2017 | Alexandra Thompson |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer